Nachrichten zur AstraZeneca PLC Aktie

FDA grants Fast Track to Ionis and AstraZenecas ATTR-CM treatment By Investing.com

FDA grants Fast Track to Ionis and AstraZenecas ATTR-CM treatment…

Ionis (IONS) Eplontersen Gets Fast Track Tag for New Indication

The FDA bestows a Fast Track designation to Ionis (IONS) and partner AstraZenecas (AZN) eplontersen for treating adults with transthyretin-mediated…

Pharma Stock Roundup: AZN & LLYs Q4 Earnings, NVO, NVS & MRKs M&A Deals

Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.…

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2023.…

AstraZeneca CEO Says China Has Become Fundamental Part of Pharma Industry

After AstraZeneca reported lower-than-expected profit, CEO Pascal Soriot spoke with Bloombergs Anna Edwards, Kriti Gupta and Guy Johnson. (Source: Bloomberg)…

AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation

…

AstraZeneca CEO Says Market Access Is Turning Pharma Off the UK

Hurdles in bringing drugs to market in the UK is putting pharmaceutical companies off investing, said the chief executive officer…

AstraZenecas earnings top estimates but shares fall on core operating profit drop By Investing.com

AstraZenecas earnings top estimates but shares fall on core operating profit drop…

Astrazeneca says Catalent deal shows importance of in-house capacity By Reuters

Astrazeneca says Catalent deal shows importance of in-house capacity…

Pharmakonzern AstraZeneca steuert auf weiteren Gewinnanstieg zu

Frankfurt (Reuters) - Der britische Pharmakonzern AstraZeneca setzt auf gute Geschäfte mit seinem neuen RSV-Antikörper sowie seinen Krebsmedikamenten und erwartet…

Lukratives Krebsgeschäft beschert Astrazeneca Gewinnsprung

CAMBRIDGE (dpa-AFX) - Ein gutes Geschäft mit Krebsmedikamenten gleicht bei Astrazeneca den Umsatzschwund mit Covid-Produkten…

AstraZeneca core earnings lagged estimates

…

AstraZeneca (AZN) Q4 Earnings & Sales Miss Estimates, Stock Down

AstraZeneca (AZN) marginally misses fourth-quarter estimates for earnings and sales. It expects revenues and EPS to increase at a low…

AstraZeneca, Compass, SSE and BAT: Day ahead on Thursday

Having lost its number one spot on the FTSE 100 last year, AstraZeneca PLC (LSE:AZN) boss Pascal Soriot will no doubt be…

AstraZeneca invests $300 million in Maryland facility By Investing.com

AstraZeneca invests $300 million in Maryland facility…

AstraZeneca facing three big investor debates as results loom, says Barclays

AstraZeneca PLC (LSE:AZN) shares have continued their underperformance from the final quarter of last year into January, with Barclays identifying three...…

Zentalis: Leading WEE1 Developer After AstraZenecas Exit

…

AstraZeneca (AZN) to Report Q4 Earnings: Heres What to Expect

Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…

AstraZenecas Q4 Earnings: Recognizing The Underrated Gems Growth

…

AstraZenecas mini acquisition spree comes as core oncology drugs face pressure

AstraZeneca PLC (LSE:AZN) recently committed to reporting how its business impacts nature as part of annual corporate results, but next…

Total Voting Rights

1 February 2024 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZenecas (AZN) sBLA for Enhertu Gets FDAs Priority Tag

AstraZenecas (AZN) sBLA for Enhertu to treat metastatic HER2-positive solid tumors gets priority review status by the FDA. A final…

AstraZeneca: Ersteinschätzung

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol:…

Hepatocellular Carcinoma Drugs (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors) Industry Report 2024: A $1.62 Billion Market Opportunity by 2028

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Drugs Global Market Report 2024" report has been…

AstraZeneca: "buy"

Charlotte (www.aktiencheck.de) - Rating-Update: Die Analysten von BofA Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG,…

AstraZenecas (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Data from a late-stage shows that AstraZenecas (AZN) cancer combination therapy reduces the risk of disease progression or death in…

The Zacks Analyst Blog Highlights Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific

Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific are included in this Analyst Blog.…

AstraZeneca: Warum jetzt der richtige Zeitpunkt zum Investieren sein könnte

Hältst du nach einer Investitionsmöglichkeit Ausschau, die nicht nur heute, sondern auch in Zukunft Früchte tragen könnte? Dann lass uns…

AstraZeneca reports positive liver cancer study results for Imfinzi

…

Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled

…

Top Research Reports for Microsoft, Procter & Gamble & AstraZeneca

Todays Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company…

AstraZeneca: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol:…

DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf Hold

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

GSK and AstraZeneca: an upgrade and a downgrade from this investment bank

UBS has revised its stance on two major UK-listed pharma companies – GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) – with…

AstraZeneca, LSE and Heathrow among 320 cos to make nature-based disclosures in financial results

Over 300 companies, including AstraZeneca, Anglo American, Endeavour Mining, Heathrow Airport and British American Tobacco, will start to include...…

JEFFERIES stuft ASTRAZENECA auf Hold

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca vor Zahlen auf "Hold" mit einem Kursziel…

Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K.…

AstraZeneca says no supply snags so far from Red Sea disruptions By Reuters

AstraZeneca says no supply snags so far from Red Sea disruptions…

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca

Eli Lilly, Novo Nordisk, Amgen and AstraZeneca are included in this Analyst Blog.…

AstraZeneca Plc Digital Transformation Strategies Report 2023: Accelerators, Incubators, and Other Innovation Programs

Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been…

AstraZeneca: Rebound in 2024 With Double-Digit Earnings Growth

Stocks Analysis by MarketBeat.com (Kate Stalter) covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, Bristol-Myers Squibb Company.…

Daiichi Sankyo rises on reported FDA filing for cancer drug developed with AstraZeneca

…

BUSINESS WIRE: Omniose gibt wissenschaftliche Zusammenarbeit mit AstraZeneca zur Erforschung von Impfstoffen gegen ernsthafte bakterielle Erkrankungen bekannt

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Dank der Zusammenarbeit erhält AstraZeneca exklusive Rechte…

dpa-AFX ProFeed